![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Drug Research
Zymo Research Announces Partnership with Tecan for COVID-19 Viral RNA Extraction
Zymo Research announced a partnership with Tecan to launch a ready-to-go processing solution to streamline viral DNA/RNA extraction from nasopharyngeal swabs, oropharyngeal swabs, saliva,...
Drug Research
Scientists on Standby portal launched to support the recruitment of overflow resource for the testing of COVID-19
Scientists on Standby has been rapidly conceptualised and launched in response to the COVID-19 crisis and in anticipation of the increasing pressure on UK...
Press Releases
PCR Biosystems continues to scale up operations to ensure ongoing availability of COVID-19 test reagents
PCR Biosystems, the UK-based PCR experts, are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to...
Drug Research
N4 Pharma exploring how Nuvec can be used to help fight COVID-19
N4 Pharma Plc , the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, announces that it will be...
News
Labguru integrates free video conferencing & documenting tool to support remote lab collaboration during COVID-19
Electronic laboratory notebook (ELN) pioneer, BioData announces its support for the global science community with the introduction of a new video conferencing service in its leading Labguru...
Press Releases
Expert System Grants Researchers Access to AI-Based CRN Tool
Expert System joins the fight against COVID-19 by granting biomedical researchers worldwide free access to its AI-based Clinical Research Navigator (CRN) tool effective immediately...
News
Mologic and partners begin validation process for COVID-19 point-of-need diagnostic test
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read